These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27462019)

  • 21. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
    Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
    J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
    Hu R; Hu F; Xie X; Wang L; Li G; Qiao T; Wang M; Xiao H
    Tumour Biol; 2016 Sep; 37(9):12181-12191. PubMed ID: 27225290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.
    Wu M; Tu T; Huang Y; Cao Y
    BMC Cancer; 2013 Feb; 13():44. PubMed ID: 23374247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells.
    Lv FZ; Wang JL; Wu Y; Chen HF; Shen XY
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):77-84. PubMed ID: 25816409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
    Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
    J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma.
    Zhang D; Wang H; He H; Niu H; Li Y
    Thorac Cancer; 2017 Jul; 8(4):337-343. PubMed ID: 28544512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of WWP2 suppresses proliferation, and induces G1 cell cycle arrest and apoptosis in liver cancer cells.
    Xu SQ; Qin Y; Pan DB; Ye GX; Wu CJ; Wang S; Jiang JY; Fu J; Wang CJ
    Mol Med Rep; 2016 Mar; 13(3):2261-6. PubMed ID: 26783238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
    Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
    Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzo(a)pyrene promotes migration, invasion and metastasis of lung adenocarcinoma cells by upregulating TGIF.
    Yang H; Zhang H; Pan T; Wang H; Wang Y
    Toxicol Lett; 2018 Sep; 294():11-19. PubMed ID: 29746904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
    Li J; Zhang W; Xia H; Liu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
    Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
    Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lentivirus-mediated RNAi knockdown of NEDD9 on human lung adenocarcinoma cells in vitro and in vivo.
    Chang JX; Gao F; Zhao GQ; Zhang GJ
    Oncol Rep; 2014 Oct; 32(4):1543-9. PubMed ID: 25051398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of protease-activated receptor 4 in lung adenocarcinoma is associated with a more aggressive phenotype.
    Jiang P; Yu GY; Zhang Y; Xiang Y; Hua HR; Bian L; Wang CY; Lee WH; Zhang Y
    Asian Pac J Cancer Prev; 2013; 14(6):3793-8. PubMed ID: 23886184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.